Here is the registration for the first trial that has now completed. It was a Dose Study to Determine the Safety, Tolerability of of the cream: https://clinicaltrials.gov/ct2/show/NCT02976779
It is called "MGC cream" or "MCG ointment" and is a (now patented) Maximal dose of 30 mg CBD : 30 mg THC, 1:1 ratio or 3% THC and 3% CBD.
OWC has performed a 6-week safety study on 26 healthy subjects in one of Israel’s leading academic medical centers. The safety study demonstrated that the ointment remained topical with little to no penetration to the blood system (and thus induced no psychoactive side effects), and with nearly no local side effects. The pre-clinical study was performed at the Dead Sea Laboratory for Skin Biochemistry and Biotechnology in Ein Gedi, Israel. The subsequent safety clinical study was performed at a leading academic medical center in Israel. I believe that was Sheba.